NCT06339190 · RECRUITING
Neurofilament Light Chain And Voice Acoustic Analyses In Dementia Diagnosis
This cohort study is looking at whether a blood test for neurofilament light chain, a protein that signals nerve cell damage, plus a short speech test can help doctors diagnose dementia. Participants give one blood sample and do a speech test, then follow up at 12 months. No phase was listed. It is an observational study, not a treatment trial.
You may qualify if
- All patients presenting to Eastern Health services with a cognitive complaint or potential neurodegenerative disorder
You're excluded if
- Prognosis \<12 months
- No cognitive complaint
- Patients not involved within the single healthcare network
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-10-08